Development and validation of a biochemical recurrence risk assessment model for prostate cancer based on TCGA database
This assessment model is a relatively accurate biochemical recurrence prediction tool for prostate cancer and can guide the treatment of prostate cancer.
Authors
- Yihan Kang
- Mingshan Li (ORCID: https://orcid.org/0000-0002-3371-1023)
- Aijun Zhang (ORCID: https://orcid.org/0000-0003-4558-2051)
- Jingyu Li
- Qu Qi
- Mingyuan Li
Institutions
- Wuhan Wudong Hospital (CN)
- Fourth Affiliated Hospital of China Medical University (CN)
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
- China Medical University (CN)
Publication Details
- Journal
- Translational Andrology and Urology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.21037/tau-2025-aw-840
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00